Cardiac device implantation in the United States from 1997 through 2004: A population-based analysis

Journal of General Internal Medicine

Volumn 23, Issue 1 SUPPL., 2008, Pages 13-19

  Zhan, Chunliu ^a   Baine, William B ^a   Sedrakyan, Artyom ^a   Steiner, Claudia ^a  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

Administrative data; Cardiac resynchronization therapy; ICD 9 CM; Implantable cardioverter defibrillator; Pacemaker

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CHILD; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; DATA ANALYSIS; DEFIBRILLATOR; DEVICE; EMERGENCY PATIENT; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEALTH ECONOMICS; HEART; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEWBORN; PACEMAKER; PERIOPERATIVE PERIOD; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEALTH CARE SURVEYS; HOSPITAL CHARGES; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INFANT; INTERNATIONAL CLASSIFICATION OF DISEASES; LENGTH OF STAY; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACEMAKER, ARTIFICIAL; PROBABILITY; RISK ASSESSMENT; SEX FACTORS; UNITED STATES;

EID: 37349020985     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0392-0     Document Type: Article

References (47)

1. Maisel WH. Cardiovascular device development: lessons learned from pacemaker and implantable cardioverter-defibrillator therapy. Am J Ther. 2005;12(2):183-5.
2. Pavia S, Wilkoff B. The management of surgical complications of pacemaker and implantable cardioverter-defibrillators. Curr Opin Cardiol. 2001;16(1):66-71.
3. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA. 2006;295(7):809-18.
4. Bernstein AD, Parsonnet V. Survey of cardiac pacing and defibrillation in the United States in 1993. Am J Cardiol. 1996;78(2):187-96.
5. Bernstein AD, Parsonnet V. Survey of cardiac pacing and implanted defibrillator practice patterns in the United States in 1997. Pacing Clin Electrophysiol. 2001;24(5):842-55.
6. Daley WR, Kaczmarek RG. The epidemiology of cardiac pacemakers in the older US population. J Am Geriatr Soc. 1998;46(8):1016-9.
7. Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J. 2004;147(4):582-6.
8. Maisel WH, American Cardiology C, American Heart A, North American Society of Pacing and Electrophysiology. Impact of expanding indications on the safety of pacemakers and defibrillators. Cardiac Electrophysiology Review. 2003;7(1):30-2.
9. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA. 2003;289(6):730-40.
10. Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy. Part 2: Issues during and after device implantation and unresolved questions. J Am Coll Cardiol. 2005;46(12):2168-82.
11. Leon AR, Abraham WT, Curtis AB, et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol. 2005;46(12):2348-56.
12. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539-49.
13. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289(20):2685-94.
14. Wiegand UK, Bode F, Bonnemeier H, Eberhard F, Schlei M, Peters W. Long-term complication rates in ventricular, single lead VDD, and dual chamber pacing. Pacing Clin Electrophysiol. 2003;26(10):1961-9.
15. Wiegand UK, LeJeune D, Boguschewski F, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/ anticoagulation therapy. Chest. 2004;126(4):1177-86.
16. Rozmus G, Daubert JP, Huang DT, Rosero S, Hall B, Francis C. Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. Journal Interventional Cardiac Electrophysiology. 2005;13(1):9-19.
17. Tri JL, Trusty JM, Hayes DL. Potential for Personal Digital Assistant interference with implantable cardiac devices. Mayo Clin Proc. 2004;79(12):1527-30.
18. Sweeney MO, Shea JB, Ellison KE. Upgrade of permanent pacemakers and single chamber implantable cardioverter defibrillators to pectoral dual chamber implantable cardioverter defibrillators: indications, surgical approach, and long-term clinical results. Pacing Clin Electrophysiol. 2002;25(12):1715-23.
19. Maisel WH. Pacemaker and ICD generator reliability: meta-analysis of device registries. JAMA. 2006;295(16):1929-34.
20. Hammill S, Phurrough S, Brindis R. The national ICD registry: now and into the future. Heart Rhythm. 2006;3(4):470-3.
21. NCC-NCDR National Cardivascular Data Registry, ICD Registry. Available at http://www.accncdr.com/webncdr/ICD/Default.aspx ; Accessed Nov. 1, 2006.
22. Maisel WH, Moynahan M, Zuckerman BD, et al. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA. 2006;295(16):1901-6.
23. Wilkoff BL. Pacemaker and ICD malfunction-an incomplete picture. JAMA. 2006;295(16):1944-6.
24. Gould PA, Krahn AD. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA. 2006;295(16):1907-11.
25. Maisel WH, Stevenson WG, Epstein LM. Changing trends in pacemaker and implantable cardioverter defibrillator generator advisories. Pacing Clin Electrophysiol. 2002;25(12):1670-8.
26. Maisel WH, Sweeney MO, Stevenson WG, Ellison KE, Epstein LM. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. [See comment]. JAMA. 2001;286(7):793-99.
27. Bernstein AD, Parsonnet V. Survey of cardiac pacing in the United States in 1989. Am J Cardiol. 1992;69(4):331-8.
28. Mond HG, Irwin M, Morillo C, Ector H. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2001. Pacing Clin Electrophysiol. 2004;27(7):955-64.
29. Zhan C, Miller M. Administrative data-based patient safety research: a critical review. Quality and Safety of Health Care. 2003;12(Suppl II):II58-II63.
30. Agency for Healthcare Research and Quality. Healthcare Cost & Utilization Project. Available at http://www.ahrq.gov/data/hcup/ Accessed July 20, 2006.
31. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.
32. Curtis AB, Ellenbogen KA, Hammill SC, et al. Clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. [See comment]. Heart Rhythm. 2004;1(3):371-5.
33. Tobin K, Stewart J, Westveer D, Frumin H. Acute complications of permanent pacemaker implantation: their financial implication and relation to volume and operator experience. Am J Cardiol. 2000;85(6):774-6.
34. Parsonnet V, Bernstein AD, Lindsay B. Pacemaker-implantation complication rates: an analysis of some contributing factors. J Am Coll Cardiol. 1989;13(4):917-21.
35. Agency for Healthcare Research and Quality. Guide to Patient Safety Indicators. Available at: http://www.qualityindicators.ahrq.gov/psi_download. htm. Accessed July 20, 2006. Rockville, MD: Agency for Healthcare Research and Quality; 2006.
36. Agency for Healthcare Research and Quality. National Healthcare Quality Report, 2006. Available at: http://www.ahrq.gov/qual/nhqr06/index.html#Safety. Accessed April 17, 2007. Rockville, MD: Agency for Healthcare Research and Quality, 2006.
37. Gupta A, Zegel HG, Dravid VS, Nierenberg SJ, Freiman DB. Value of radiography in diagnosing complications of cardioverter defibrillators implanted without thoracotomy in 437 patients. AJR Am J Roentgenol. 1997;168(1):105-8.
38. Pfeiffer D, Jung W, Fehske W, et al. Complications of pacemaker-defibrillator devices: diagnosis and management. Am Heart J. 1994;127(4 Pt 2):1073-80.
39. Harcombe AA, Newell SA, Ludman PF, et al. Late complications following permanent pacemaker implantation or elective unit replacement. Heart. 1998;80(3):240-4.
40. Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RG. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br Heart J. 1995;73(6):571-5.
41. Jones GK, Bardy GH, Kudenchuk PJ, et al. Mechanical complications after implantation of multiple-lead nonthoracotomy defibrillator systems: implications for management and future system design. Am Heart J. 1995;130(2):327-33.
42. Kiviniemi MS, Pirnes MA, Eranen HJ, Kettunen RV, Hartikainen JE. Complications related to permanent pacemaker therapy. Pacing Clin Electrophysiol. 1999;22(5):711-20.
43. Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97(18):1796-801.
44. del Rio A, Anguera I, Miro JM, et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest. 2003;124(4):1451-9.
45. Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997;95(8):2098-107.
46. Santucci PA, Haw J, Trohman RG, Pinski SL. Interference with an implantable defibrillator by an electronic antitheft-surveillance device. N Engl J Med. 1998;339(19):1371-4.
47. Link MS, Estes NA 3rd, Griffin JJ, et al. Complications of dual chamber pacemaker implantation in the elderly. Pacemaker Selection in the Elderly (PASE) Investigators. Journal of Interventional Cardiac Electrophysiology. 1998;2(2):175-9.